title: Peritonitis due to Comamonas acidovorans in a CAPD patient.
authors.forename: R
authors.initials: R
authors.lastname: López-Menchero
authors.forename: F
authors.initials: F
authors.lastname: Sigüenza
authors.forename: A
authors.initials: A
authors.lastname: Caridad
authors.forename: J C
authors.initials: JC
authors.lastname: Alonso
authors.forename: R M
authors.initials: RM
authors.lastname: Ferreruela
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D016946:Gram-Negative Aerobic Rods and Cocci; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D012008:Recurrence; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D002939:Ciprofloxacin; D014640:Vancomycin; D002442:Ceftazidime